About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT06070870

Health Education Approach to Lung Screening

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

Lead sponsor: Virginia Commonwealth University•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Massey IIT Research Operations

CONTACT

804-628-6430 masseyepd@vcu.edu

Sponsors

Lead Sponsor

Virginia Commonwealth University

Collaborators

Stand Up To Cancer

This is a single-arm study of a patient navigation intervention to increase access to lung cancer screening (LCS).

Age

50 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Meets current USPSTF guidelines for lung cancer screening (LCS)
•20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.
•One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year.
•Currently smokes or has quit smoking within the past 15 years
•Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
•Willing to complete all navigation-related study activities
•Able to understand and the willingness to sign a written informed consent document

Exclusion Criteria

•Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
•Has undergone a previous lung cancer screening
•Inability to speak English
•Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements

Related studies

RECRUITINGPhase 1

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937 · Small Cell Lung Cancer, Melanoma, and more

RECRUITINGPhase 3

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510 · Non Small Cell Lung Cancer

RECRUITINGPhase 1/2

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more

RECRUITINGPhase 2

ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

NCT06426511 · Lung Cancer, Nonsmall Cell

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

NCT03563976 · Lung Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 16, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment675

Start dateOct 2023

Last updatedMar 16, 2026

Condition

Locations shown

University of North Carolina-Chapel Hill

Carrboro, North Carolina

Medical University of South Carolina

Charleston, South Carolina

Virginia Commonwealth University

Richmond, Virginia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 16, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions